genXone S.A. (WSE:GX1)
Poland · Delayed Price · Currency is PLN 5.58
-0.06 (-1.06%)
At close: Jul 24, 2026
genXone Revenue
genXone had revenue of 490.93K PLN in the quarter ending March 31, 2026, with 14.96% growth. This brings the company's revenue in the last twelve months to 2.41M, up 27.30% year-over-year. In the year 2025, genXone had annual revenue of 2.34M with 31.07% growth.
Revenue (ttm)
2.41M
Revenue Growth
+27.30%
P/S Ratio
7.66
Revenue / Employee
141.61K
Employees
17
Market Cap
18.44M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.34M | 555.51K | 31.07% |
| Dec 31, 2024 | 1.79M | -606.63K | -25.33% |
| Dec 31, 2023 | 2.39M | -8.19M | -77.38% |
| Dec 31, 2022 | 10.59M | -12.61M | -54.36% |
| Dec 31, 2021 | 23.20M | 2.72M | 13.29% |
| Dec 31, 2020 | 20.47M | 20.27M | 9,907.43% |
| Dec 31, 2019 | 204.59K | 147.86K | 260.66% |
| Dec 31, 2018 | 56.73K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| NEUCA | 13.83B |
| Diagnostyka | 2.51B |
| Synektik Spólka Akcyjna | 794.94M |
| Voxel | 583.14M |
| InventionMed | 3.74M |
| Pharmena | 1.61M |
| Airway Medix | 89.00K |
| Stem Cells Spin | 65.18K |